A new posthoc analysis of data from the Valsartan Heart Failure Trial (Val-HeFT) has confirmed that atrial fibrillation (AF) is independently associated with an increased risk of all-cause mortality ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results